Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Properties left behind in market rally

Tue, 18th Aug 2009 12:00

Once again mining stocks are in the driving seat but today they are driving the market north, with many stocks recovering some of yesterday's heavy losses.Xstrata, ENRC, Kazakhmys and Lonmin are the picks of the mining sector, along with cash strapped Rio Tinto, which has received a $2.025bn offer for the majority of its Alcan Packaging business. Rio said the binding offer has been received from Amcor and covers the Alcan Packaging global pharmaceuticals, global tobacco, food Europe and food Asia divisions. British Land's results have disappointed and cast a shadow over the real estate sector. The property group, which owns the Broadgate development in London's financial district, saw the value of its property portfolio fall to £8.18bn in the first quarter but said the pace of decline has slowed markedly. Land Securities and Liberty International slide in sympathy.Elsewhere in the financial sector HSBC is wanted after positive comment from Goldman Sachs. The US bank reckons that HSBC Finance will stop being a major drag on HSBC's earnings from 2010 onwards, earlier than previously expected. Goldman Sachs has upgraded HSBC from 'neutral' to 'buy' and raised its price target from 580p to 820p.A joint venture including support services firm Carillion has won a 'Building Schools for the Future' contract for Durham. The market has given the thumbs up to James Fisher's acquisition of MB Faber, which provides specialist electrical and engineering services to the nuclear and aerospace industries, for up to £5.25m in cash.Car dealer Pendragon reported sharply lower profits in the six months to June 30 as recession-hit motorists held onto their old cars rather than splashing out on new ones. Respiratory inhaler firm Vectura remains "very confident" about prospects with important drug trials due to start later this year and plenty of cash in the bank.Online video services provider Amino Technologies posted an operating loss compared with a profit the same time a year before as challenging economic conditions continued hit the group. Nightclub owner Luminar can breathe a little easier on news that 95.5% of the shares available through an open offer have been taken up and buyers have been found for the remainder.Chip designer Arc International is recommending a £25.2m cash bid from US semiconductor intellectual property firm Virage Logic.The slump in construction activity hit property repair and maintenance company Rok hard in the first half of 2009, but the company is confident of meeting full year expectations, provided market conditions do not deteriorate further.Australian alternative energy developer Ceramic Fuel Cells revealed widening annual losses after it booked significant impairment charges related to losses on financial investments.US navigation equipment specialist Garmin said any offer it makes for marine electronics group Raymarine is likely to be solely in cash. Yesterday, Raymarine confirmed recent press speculation that it is in potential takeover talks with US navigation equipment specialist Garmin and with other parties.Zambia-based exploration company Kiwara said its follow-up drill programme has significantly extended the size of the strike at the company's mne in Kawako.India-focused oil and gas company Indus Gas has discovered gas on a test drilling of a new well. The Eastern Promise-1 well intersected a gas bearing interval at a depth of around 3,175 to 3,183 metres in the Early Cretaceous Pariwar formation.Trading in the shares of Dominion Petroleum resumed after the Bermuda-based oil and gas explorer announced a cash injection and its results for 2008. The company is to raise $10m through the issue of new shares to BlueGold Capital. The share purchase will give BlueGold a 20% stake in Dominion. The company said it made a pre-tax loss of $20.67m in 2008, an improvement on the $24.50m loss made in 2007.FTSE 100 - RisersXstrata (XTA) 775.50p +4.51%Eurasian Natural Resources (ENRC) 784.50p +3.43%Kazakhmys (KAZ) 892.00p +3.30%Rio Tinto (RIO) 2,318.50p +3.25%FTSE 100 - FallersInvensys (ISYS) 245.60p -2.77%Land Securities Group (LAND) 597.00p -2.13%British Land Co (BLND) 486.80p -1.89%Petrofac Ltd (PFC) 865.50p -1.87%
More News
8 Apr 2016 15:55

LONDON MARKET CLOSE: Oil Rally Helps FTSE 100 To Highest 2016 Close

Read more
8 Apr 2016 11:10

LONDON MARKET MIDDAY: "Risky" Oil Price Rally Supports Stocks

Read more
8 Apr 2016 09:56

WINNERS & LOSERS SUMMARY: Pathfinder Sinks After Mozambique Ruling

Read more
8 Apr 2016 07:37

LONDON MARKET OPEN: Resource Stocks Lead Gainers As Oil Recovers

Read more
8 Apr 2016 06:48

US Accepts Hikma, Vectura Filing For Generic Of Glaxo's Advair Diskus

Read more
1 Apr 2016 15:46

Broker tips: ARM, Tate & Lyle, Inchcape

(ShareCast News) - Numis sell-side analysts provided a list of their top picks among large and small cap stocks across the market, including ARM Holdings, Virgin Money, Derwent London, Tullow Oil, Northgate and Vectura. After another strong set of quarterly results, ARM remains the top pick as Numis

Read more
1 Apr 2016 15:34

Numis adds Virgin Money, Derwent and Northgate to 'top picks' list

(ShareCast News) - Numis sell-side analysts provided a list of their top picks among large and small cap stocks across the market, including ARM Holdings, Virgin Money, Derwent London, Tullow Oil, Northgate and Vectura. After another strong set of quarterly results, ARM remains the top pick as Numis

Read more
17 Mar 2016 11:52

Vectura receives support from Skyepharma shareholder

(ShareCast News) - Vectura - which focuses on the development of pharmaceutical therapies for airways diseases - has received a letter of intent from a Skyepharma shareholder supporting the companies' proposed merger. Vectura said River and Mercantile Asset Management, which owns just under 4.8m Sky

Read more
17 Mar 2016 11:15

Vectura Gets Support From Skyepharma Shareholder For Takeover (ALLISS)

Read more
16 Mar 2016 12:26

UPDATE 1-Vectura to buy SkyePharma for $620 mln as UK biotech consolidates

* Agreed offer values SkyePharma at 410.15 pence a share * Combined group market value more than 1 billion pounds (Adds more on rationale for deal, comment from CEO) By Ben Hirschler LONDON, March 16 (Reuters) - Respiratory drug specialist Vectura has agreed to buy rival SkyeP

Read more
16 Mar 2016 09:06

Skyepharma Agrees To Merge With Vectura As It Swings To Profit (ALLISS)

Read more
16 Mar 2016 08:55

Skyepharma and Vectura agree merger; Skyepharma swings to profit

(ShareCast News) - Vectura and Skyepharma have reached an agreement on the terms of a recommended merger. Under the terms of the deal, Skyepharma shareholders will get 2.7977 new Vectura shares for each Skyepharma share. Based on Vectura's closing price of 146.60p on Tuesday, this values Skyepharma

Read more
10 Feb 2016 16:22

Wednesday broker round-up

(ShareCast News) - Virgin Money: Nomura starts coverage at buy with a target of 445p. Domino's Pizza: Credit Suisse upgrades to outperform with a target price of 1100p. BBA Aviation: Goldman Sachs downgrades to neutral with 181p target. Greencore: Societe Generale reiterates hold with a 386p targe

Read more
10 Feb 2016 08:43

Milestone payday for Vectura on new asthma therapy

(ShareCast News) - Vectura Group's inhaler and formulation technology received a boost on Wednesday, with the completion of a significant milestone on the development of the VR315 product. The FTSE 250 company confirmed that the clinical study report had been finalised, triggering a cash milestone p

Read more
10 Feb 2016 08:07

Vectura Gets GBP2 Million Milestone Payment After VR315 Trial

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.